143 related articles for article (PubMed ID: 21989346)
1. Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases.
Duregon E; Volante M; Cappia S; Cuccurullo A; Bisceglia M; Wong DD; Spagnolo DV; Szpak-Ulczok S; Bollito E; Daffara F; Berruti A; Terzolo M; Papotti M
Am J Surg Pathol; 2011 Dec; 35(12):1882-93. PubMed ID: 21989346
[TBL] [Abstract][Full Text] [Related]
2. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.
Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M
Am J Surg Pathol; 2013 Sep; 37(9):1433-40. PubMed ID: 23774167
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
[TBL] [Abstract][Full Text] [Related]
4. The Weiss score and beyond--histopathology for adrenocortical carcinoma.
Papotti M; Libè R; Duregon E; Volante M; Bertherat J; Tissier F
Horm Cancer; 2011 Dec; 2(6):333-40. PubMed ID: 21997290
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification.
Volante M; Bollito E; Sperone P; Tavaglione V; Daffara F; Porpiglia F; Terzolo M; Berruti A; Papotti M
Histopathology; 2009 Nov; 55(5):535-43. PubMed ID: 19912359
[TBL] [Abstract][Full Text] [Related]
6. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
[TBL] [Abstract][Full Text] [Related]
7. Overview of the 2022 WHO Classification of Adrenal Cortical Tumors.
Mete O; Erickson LA; Juhlin CC; de Krijger RR; Sasano H; Volante M; Papotti MG
Endocr Pathol; 2022 Mar; 33(1):155-196. PubMed ID: 35288842
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of adrenocortical cancer.
Lehmann T; Wrzesinski T
Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
[TBL] [Abstract][Full Text] [Related]
9. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
[TBL] [Abstract][Full Text] [Related]
10. Weiss criteria in large adrenocortical tumors: a validation study.
Jain M; Kapoor S; Mishra A; Gupta S; Agarwal A
Indian J Pathol Microbiol; 2010; 53(2):222-6. PubMed ID: 20551521
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Adrenocortical Tumors by Reticulin Algorithm.
Fonseca D; Murthy SS; Tagore KR; Rao BV; Thamminedi SR; Raju KVVN; Sharma R; Challa S
Indian J Endocrinol Metab; 2017; 21(5):734-737. PubMed ID: 28989884
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates.
Duregon E; Volante M; Giorcelli J; Terzolo M; Lalli E; Papotti M
Hum Pathol; 2013 May; 44(5):822-8. PubMed ID: 23158211
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
[TBL] [Abstract][Full Text] [Related]
14. A rare case of oncocytic adrenocortical carcinoma clinically presented as an incidentaloma.
Harada K; Yasuda M; Nakano Y; Yoshida K; Umeda Y; Yagi T; Yamazaki Y; Sasano H; Otsuka F
Endocr J; 2020 Aug; 67(8):883-888. PubMed ID: 32249250
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical carcinoma: clinical and laboratory observations.
Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
[TBL] [Abstract][Full Text] [Related]
16. Pathological and molecular features of adrenocortical carcinoma: an update.
Volante M; Buttigliero C; Greco E; Berruti A; Papotti M
J Clin Pathol; 2008 Jul; 61(7):787-93. PubMed ID: 18430754
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Adrenocortical Neoplasms: A Study Comparing Three Histopathological Scoring Systems.
Jangir H; Ahuja I; Agarwal S; Jain V; Meena JP; Agarwala S; Sharma R; Sharma MC; Iyer VK; Mani K
Endocr Pathol; 2023 Jun; 34(2):213-223. PubMed ID: 37160532
[TBL] [Abstract][Full Text] [Related]
18. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
Menon V; Krishnamurthy SV
Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
[TBL] [Abstract][Full Text] [Related]
20. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
